
CytoDyn (OTC: CYDY) Files Request With FDA for Priority Review of BLA for First Approval
VANCOUVER, Washington, Jun 01, 2020 — If granted, the FDA is expected to take action on the Company’s BLA within six months CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing […]